The first patient has been dosed in an ongoing phase 1/2a clinical trial with a new thaw-and-inject formulation of OpRegen, delivered with the Orbit subretinal delivery system, BioTime announced in a press release.The open-label, dose escalation trial …
Custom 3D Printed Robotic Surgical Instruments for Every Patient
Today’s arthroscopic instruments that are used to perform minimally invasive procedures on hips, knees, and other parts of the body, are rigid devices. They also tend to be one-size-fits-all solutions that surgeons have to use on patients with varied anatomies. Now, a team at the Australian Centre for Robotic Vision are working on being able (Read more...)
Children’s Hospital Los Angeles Has Treated 14 Patients With Retinal Degeneration Using Gene Therapy
LOS ANGELES–(BUSINESS WIRE)–The Vision Center at Children’s Hospital Los Angeles performs revolutionary gene replacement surgery to restore children’s vision.
VIDEO: Industry updates from CorneaGen CEO Monty Montoya
Test.docx
Prism Vision Group Announces Launch of New Brand
UNION, N.J.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/PrismVisionGroup?src=hash" target="_blank">#PrismVisionGroup</a>–Today, company officials announced the launch of Prism Vision Group, the largest ophtha…
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank">$OCUL</a> <a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank">#OCUTX…